NCT02061631 Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck Status COMPLETED Phase PHASE2
NCT02061124 Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota Status COMPLETED Phase NA
NCT02058160 Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02058147 Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM Status COMPLETED Phase PHASE3
NCT02057250 To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02049034 Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02046629 A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers Status COMPLETED Phase PHASE1
NCT02046538 Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT02045030 Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT02044354 Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT02035605 A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients Status COMPLETED Phase PHASE1
NCT02032108 Effects of Lifestyle Education Programs on Diabetes Control in Rwanda Status COMPLETED Phase NA
NCT02027753 Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy Status COMPLETED Phase PHASE4
NCT02023879 Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II) Status COMPLETED Phase PHASE3
NCT02009345 Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada Status RECRUITING Phase N/A
NCT02006225 Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. Status UNKNOWN Phase PHASE4
NCT01985191 A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients Status COMPLETED Phase PHASE1
NCT01981668 The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation Status WITHDRAWN Phase PHASE1